Achieve precise diagnosis: Hypertensive syndromes during pregnancy secondar
y to placental ischemia still cause threatening maternofetal complications.
A precise differential diagnosis between gestational hypertension, chronic
hypertension and preeclampsia must be achieved as the management protocols
are quite different.
Patient monitoring: Blood tests for urea, creatinine, platelet counts, coag
ulation, and liver enzymes are required. Fetal monitoring, urine protein an
d ambulatory blood pressure measurements are also helpful. Ultrasound-Duple
x explorations allow an evaluation of the maternal vascular status and feta
l development
Therapeutic management: These patients should be managed in specialized cen
ters, limiting the minimum the number of hospitalizations. Unlike good rule
s of hygiene and dietetics, antihypertensive therapy has little effect on t
he progression of the pregnancy. An antihypertensive therapy is only warran
ted to avoid cardiovascular complications in the mother. In case of chronic
hypertension, treatment should be tailored to the measured pressures. Prud
ent antihypertensive therapy may be useful for severe gestational hypertens
ion and preeclampsia. Because of their safety profile and pharmacologic pro
perties, antihypertension drugs with central action and alph-beta-blockers
should be preferred over other drug classes.
Preventive treatment: Antiaggregates (aspirin 50 - 100 mg/d) starting at 16
weeks gestation should be reserved for high-risk pregnancies. Regular foll
ow-up, both pre and post-natally, is essential, especially in light of the
large number of women who can be expected to progress to established hypert
ensive states.